Lactulose

ATC CodeA06AD11
CAS number4618-18-2
PUB number11333
Drugbank IDDB00581
Empirical formulaC12H22O11
Molar mass (g·mol−1)342,30
Physical statesolid
Melting point (°C)163–165

Basics

Lactulose is a non-absorbable two-sugar (disaccharide) consisting of the two simple sugars D-galactose and fructose. It does not occur naturally and must therefore be produced synthetically. Lactulose is used to treat constipation and hepatic encephalopathy. It is taken orally for constipation and either orally or rectally for hepatic encephalopathy.

Lactulose was first characterized and manufactured in 1929. Its medicinal effects were discovered and described a short time later by the Austrian chemist Friedrich Petuely. Lactulose has been used medicinally since about the 1950s. The drug is on the World Health Organization's list of essential medicines.

Pharmacology

Pharmacodynamics

Constipation

Lactulose cannot be absorbed in the human small intestine and is not broken down by human enzymes, so the substance passes through the digestive tract unchanged. Lactulose is osmotically active, drawing water into the intestinal lumen. This results in softer and more easily excreted stools. Another laxative effect is produced by the fermentation of lactulose by intestinal bacteria in the colon. During this process, osmotically active and peristaltic stimulating substances are formed (e.g. acetate), but methane is also produced, which can sometimes lead to flatulence.

Hepatic encephalopathy

Lactulose is also converted in the large intestine by the bacterial flora into acids, mainly lactic and acetic acids. These cause acidification of the intestinal contents (increasing the H+ concentration in the intestine). This favors the formation of the non-absorbable ammonium ion (NH+4) from ammonia (NH3), which prevents NH3 from entering the blood from the colon. Overall, this reduces the ammonia concentration in the plasma. Lactulose is therefore effective in the treatment of hepatic encephalopathy, which is favored by elevated plasma NH3 levels.

Pharmacokinetics

After oral administration, less than 3% of the administered dose is absorbed in the small intestine. The remaining lactulose enters the large intestine, where it is partially metabolized. Even after metabolism, however, absorption of unchanged lactulose and its metabolites via the colon is negligible. Lactulose is essentially metabolized only in the colon by the saccharolytic bacteria present there. In particular, the substance is broken down into lactic acid and small amounts of acetic and formic acid. Renal excretion of the absorbed lactulose fraction has been shown to be about 3% and generally takes less than 24 hours. Most of the unabsorbed lactulose portion is excreted in the feces. Due to the low absorption, there are no reliable values for half-life, plasma protein binding, clearance and volume of distribution of the substance.

Toxicity

Side effects

Common side effects of lactulose are abdominal cramps, bowel sounds, and flatulence. Uncommon side effects include nausea and vomiting, hypokalemia with muscle weakness, constipation, and cardiac arrhythmias.

Toxicological Data

LD50, rat, oral: 18.16 g/kg

Markus Falkenstätter, BSc

Markus Falkenstätter, BSc

Mag. pharm. Stefanie Lehenauer

Mag. pharm. Stefanie Lehenauer



Logo

Your personal medication assistant

Drugs

Browse our extensive database of medications from A-Z, including effects, side effects, and dosage.

Substances

All active ingredients with their effects, applications, and side effects, as well as the medications they are contained in.

Diseases

Symptoms, causes, and treatments for common diseases and injuries.

Social media

The presented content does not replace the original package insert of the medication, especially regarding the dosage and effects of individual products. We cannot assume liability for the accuracy of the data, as the data has been partially converted automatically. Always consult a doctor for diagnoses and other health-related questions.

© medikamio